Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 7, 2006, Pages 415-419

  Kovo, Michal ^a   Weissman, Ariel ^a   Gur, Dvir ^a   Levran, David ^a   Rotmensch, Sigi ^a   Glezerman, Marek ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Birth weight percentile; Pregnancy complications

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; METFORMIN;

ADULT; ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; NEWBORN; NEWBORN JAUNDICE; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL;

ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; MALE; METFORMIN; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 33747733559     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050600682370     Document Type: Article

References (24)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
2. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HS. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988;297:1024-1026.
3. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S. Recurrent early miscarriage and polycystic ovaries. BMJ 1988;297:1027-1028.
4. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001;16:226-229.
5. de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998;76:91-95.
6. Bjercke S, Dale PO, Tanbo T, Storeng R, Ertzeid G, Abyholm T. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 2002;54:94-98.
7. Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999;94:194-197.
8. Lord JM, Flight IH, Norman RJ. Metformin in polycystic ovary syndrome: Systematic review and meta-analysis. BMJ 2003;327:951-953.
9. McCarthy EA, Walker SP, McLachlan K, Boyle J, Permezel M. Metformin in obstetric and gynecologic practice: A review. Obstet Gynecol Surv 2004;59:118-127.
10. Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiroinositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003;CD003053.
11. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study. Fertil Steril 2001;75:46-52.
12. Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA, Nestler JE. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:524-529.
13. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002;17:2858-2864.
14. Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002;77:520-525.
15. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
16. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83:2694-2698.
17. Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003;3:13.
18. Oken E,Kleinman KP, Rich-Edwards J,Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003;3:6.
19. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. Baltimore, MD, USA. Lippincott Williams & Wilkins 2002.
20. Glueck CJ, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004;19:1323-1330.
21. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: Results of a randomized study. Hum Reprod 2004;19:1734-1740.
22. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes Z, Crystal RA, Hintz RL, Rosenfeld RG. Insulin-like growth factors and their binding proteins in the term and pre-term human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555.
23. Hill DJ, Tevaarwerk GJ, Caddell C, Arany E, Kilkenny D, Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: Relationship to fetal and placental size. J Clin Endocrinol Metab 1995;80:2626-2632.
24. Norman RJ, Wang JX, Hague W. Should we continue or stop insulin sensitizing drugs during pregnancy? Curr Opin Obstet Gynecol 2004;16:245-250.